NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 75 filers reported holding NOVELION THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $61,000 | -7.6% | 84,353 | -1.2% | 0.00% | – |
| Q2 2019 | $66,000 | -36.5% | 85,409 | +0.6% | 0.00% | – |
| Q1 2019 | $104,000 | -26.8% | 84,881 | -48.8% | 0.00% | – |
| Q4 2018 | $142,000 | -15.5% | 165,802 | +191.4% | 0.00% | – |
| Q3 2018 | $168,000 | -17.2% | 56,898 | +2.7% | 0.00% | – |
| Q2 2018 | $203,000 | -31.2% | 55,425 | -34.4% | 0.00% | – |
| Q1 2018 | $295,000 | +20.9% | 84,511 | +7.9% | 0.00% | – |
| Q4 2017 | $244,000 | -9.0% | 78,354 | +105.3% | 0.00% | – |
| Q3 2017 | $268,000 | +13.1% | 38,160 | +48.4% | 0.00% | – |
| Q2 2017 | $237,000 | – | 25,722 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 1,313,387 | $4,833,000 | 13.70% |
| Stonepine Capital Management, LLC | 1,792,911 | $6,598,000 | 4.01% |
| Broadfin Capital, LLC | 1,948,554 | $7,171,000 | 1.13% |
| Sarissa Capital Management LP | 1,025,000 | $3,772,000 | 0.76% |
| JW Asset Management, LLC | 315,979 | $1,163,000 | 0.74% |
| Prosight Management, LP | 194,663 | $716,000 | 0.52% |
| ARMISTICE CAPITAL, LLC | 1,856,000 | $6,830,000 | 0.45% |
| KNOTT DAVID M | 109,184 | $402,000 | 0.15% |
| EdgePoint Investment Group Inc. | 2,195,063 | $8,078,000 | 0.10% |
| Yakira Capital Management, Inc. | 36,428 | $134,000 | 0.03% |